Patents
Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
01/2002
01/31/2002CA2416870A1 Potassium channel inhibitors
01/31/2002CA2415740A1 Pyrrolidine derivatives as metalloprotease inhibitors
01/31/2002CA2415606A1 Capsaicin receptor ligands
01/31/2002CA2354236A1 Use of glycogen phosphorylase inhibitors to inhibit tumor growth
01/30/2002EP1176141A1 HETEROCYCLIC COMPOUNDS HAVING EFFECT OF ACTIVATING NICOTINIC ACETYLCHOLINE $g(a)4$g(b)2 RECEPTOR
01/30/2002EP1176139A1 Medicinal compositions with 2.2.1] and 3.1.1] bicycloskeleton antagonistic to both of pgd 2?/txa 2? receptors
01/30/2002EP1175419A2 Aryl sulfonyls as factor xa inhibitors
01/30/2002EP1175418A2 Thiazolidinedione derivative and its use as antidiabetic
01/30/2002EP1175417A1 Substituted benzolactam compounds
01/30/2002EP1175416A1 Heteroaryl diazacycloalkanes, their preparation and use
01/30/2002EP1175412A1 Substituted bicyclic heterocycles, process for their preparation and their use as antiobesity and hypocholesterolemic agents
01/30/2002EP1175410A1 Pesticidal triazine derivatives
01/30/2002EP1175409A1 Pyrimidinones derivatives for the treatment of atherosclerosis
01/30/2002EP1175406A1 Imidazoline derivatives as alpha-1a adrenoceptor ligands
01/30/2002EP1175402A1 Piperidine derivatives useful as ccr5 antagonists
01/30/2002EP1175399A1 Inhibitors of c-jun n-terminal kinases (jnk)
01/30/2002EP1175213A2 Heterocyclic aromatic compounds useful as growth hormone secretagogues
01/30/2002EP0740689B1 Substituted unsymmetrical cyanine dyes with selected permeability
01/30/2002CN1333820A Recombinant methods and materials for producing epothilone and eopthilone derivatives
01/30/2002CN1333776A Imidazo [4,5-b] pyridiniummethyl-containing cephem compounds having broad antibacterial spectrum
01/30/2002CN1333770A Novel dicyclic compound
01/30/2002CN1333769A Thiourea inhibitors of herps viruses
01/30/2002CN1333767A Aromatic heterocyclic compounds as antiinflammatory agent
01/30/2002CN1333766A Substituted (aminoiminomethyl or aminomethyl) benzoheteroaryl compounds as factor xainhibitors
01/30/2002CN1333762A Novel 2-(N-cyanoimino) thiazolidin-4-one derivatives
01/30/2002CN1333761A Isothiazolecarboxylic acid derivatives
01/30/2002CN1333759A Acrylonitrile compounds
01/30/2002CN1333758A Substituted bicyclic derivatives useful as anticancer agents
01/30/2002CN1333685A Utilisation of I compound for the prophylaxis and therapy of cerebral ischaemia
01/29/2002US6342765 Imidazole derivatives and their use as farnesyl protein transferase inhibitors
01/29/2002US6342633 O-benzyl oxime ether derivatives and their use as pesticides
01/29/2002US6342610 Compounds such as n-(4-bromo-3-methyl-5-isoxazolyl)-2-n-benzylbenzo(b)thiophene-3-sufonamide administered as endothelin peptide receptor antagonists
01/29/2002US6342608 Reacting organometallic reagent with activated carboxylic acid to form ketone, treating with mixture of carbon disulfide and dihalomethane to form dithietane, reacting with hydrazine derivative to form thiol-substituted pyrazole, alkylating
01/29/2002US6342605 Bidentate phosphine ligand used in preparation of linear aldehyde by hydroformylating internal olefin with carbon monoxide and hydrogen
01/29/2002US6342513 Oxazolidinone antibacterial agents having a thiocarbonyl functionality
01/29/2002US6342503 Antidepressants, eating disorders
01/29/2002US6342245 Compositions of lipid lowering agents
01/29/2002CA2165996C Stereoselective preparation of 2-substituted succinic derivatives
01/28/2002CA2704691A1 Indole derivatives and their use as medicaments
01/24/2002WO2002006281A1 2-substituted thiazolidinones as beta-3 adrenergic receptor agonists
01/24/2002WO2002006280A2 INHIBITORS OF FACTOR Xa
01/24/2002WO2002006277A1 Substituted benzo-nitro-heterocycles and use thereof as herbicides
01/24/2002WO2002006276A1 Beta3 adrenergic agonists
01/24/2002WO2002006274A1 N-(4-sulfonylaryl)cyclylamine-2-hydroxyethylamines as beta-3 adrenergic receptor agonists
01/24/2002WO2002006273A1 Substituted 1-(4-aminophenyl)indoles and their use as anti-inflammatory agents
01/24/2002WO2002006272A1 Polyfluoroalkyltriazole derivatives, preparation and therapeutic use thereof
01/24/2002WO2002006270A1 Novel 6-heteroarylphenanthridines
01/24/2002WO2002006258A1 Azolidines as beta-3 adrenergic receptor agonists
01/24/2002WO2002006256A1 Heterocyclic fluoroalkenyl thioethers (ii)
01/24/2002WO2002006247A1 Substituted amidoalkyl-uracils as parp inhibitors
01/24/2002WO2002006246A1 Dihydroxypyrimidine carboxylic acids as viral polymerase inhibitors
01/24/2002WO2002006245A1 Selective melanin concentrating hormone-1 (mch1) receptor antagonists and uses thereof
01/24/2002WO2002006236A1 N-oxides as nk1 receptor antagonist prodrugs of 4-phenyl-pyridine derivatives
01/24/2002WO2002006234A1 Sulfone derivatives, process for their production and use thereof
01/24/2002WO2002006232A1 Cyclic amine phenyl beta-3 adrenergic receptor agonists
01/24/2002WO2002006230A2 Piperidino-phenyl amino squarate and thiadiazole dioxide beta-3 adrenergic receptor agonists
01/24/2002WO2002006229A2 Heterocyclic beta-3 adrenergic receptor agonists
01/24/2002WO2002006223A1 1,3-disubstituted and 1,3,3-trisubstituted pyrrolidines as histamine-3 receptor ligands and their therapeutic applications
01/24/2002WO2002006221A2 Cyclylamine sulfonamides as beta-3 adrenergic receptor agonists
01/24/2002WO2002006210A1 Phenyl amino squarate and thiadiazole dioxide beta-3 adrenergic receptor agonists
01/24/2002WO2002005819A1 Compounds and methods
01/24/2002WO2001058869A3 Cannabinoid receptor modulators, their processes of preparation, and use of cannabinoid receptor modulators in treating respiratory and non-respiratory diseases
01/24/2002WO2001032655A3 Quinoline and naphthyridine carboxylic acid antibacterials
01/24/2002WO2001027107A3 Heterocyclic sodium/proton exchange inhibitors and method
01/24/2002WO2001023357A3 Fused cycloheptane and fused azacycloheptane compounds and their use as integrin receptor antagonists
01/24/2002US20020010345 Methods for the preparation of 4-hydroxy benzothiophene
01/24/2002US20020010340 Process for preparation of 2-aminothiazolecarboxamide derivatives
01/24/2002US20020010316 Thiazole derivatives
01/24/2002US20020010315 Treatment or amelioration of symptoms of adult respiratory distress syndrome, septic shock, and multiple organ failure.
01/24/2002US20020010204 Use as pesticides.
01/24/2002US20020010187 5-((4-(3-methyl-4-oxo-3,4-dihydro-2 -quinazolinyl)methoxy)phenylmethyl)thiazolidine-2 ,4-dione or a pharmaceutically acceptable salt thereof
01/24/2002US20020010179 Ultraviolet light screening agents; cosmetics
01/24/2002US20020010177 For treating eosinophil-dependent inflammatory diseases, asthma
01/24/2002US20020010169 Substituted 1, 4-thiazepine and analogs as activators of caspases and inducers of apoptosis and the use thereof
01/24/2002US20020009650 High electroconductivity
01/24/2002US20020007522 Less selective colorations and which are particularly resistant to the various attacking factors to which the hair may be subjected
01/24/2002US20020007521 Less selective colorations and which are particularly resistant to the various attacking factors to which the hair may be subjected
01/24/2002DE10034131A1 Heterocyclische Fluoralkenylthioether (II) Heterocyclic fluoroalkenyl thioethers (II)
01/24/2002CA2418288A1 Dihydroxypyrimidine carboxylic acids as viral polymerase inhibitors
01/24/2002CA2416667A1 Cyclylamine sulfonamides as beta-3 adrenergic receptor agonists
01/24/2002CA2416384A1 Sulfone derivatives, their production and use
01/24/2002CA2416245A1 Cyclic amine phenyl beta-3 adrenergic receptor agonists
01/24/2002CA2416036A1 Substituted amidoalkyl-uracils as parp inhibitors
01/24/2002CA2415935A1 Novel 6-heteroarylphenanthridines
01/24/2002CA2415331A1 Beta3 adrenergic agonists
01/24/2002CA2415126A1 Substituted 1-(4-aminophenyl)indoles and their use as anti-inflammatory agents
01/24/2002CA2384041A1 Selective melanin concentrating hormone-1 (mch1) receptor antagonists and uses thereof
01/23/2002EP1173468A1 Integrin receptor antagonists
01/23/2002EP1173441A1 6-alkenyl-, 6-alkinyl- and 6-epoxy-epothilone derivatives, process for their production, and their use in pharmaceutical preparations
01/23/2002EP1173437A2 Thiazolidinedione derivative and its use as antidiabetic
01/23/2002EP1173436A2 Thiazolidinedione derivative and its use as antidiabetic
01/23/2002EP1173435A1 Polymorph of 5-[4-[2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione maleic acid salt
01/23/2002EP1173434A2 Thiazolidinedione derivative and its use as antidiabetic
01/23/2002EP1173428A1 O-aryl dithiazole dioxides
01/23/2002EP1173427A1 Hydroxamic acid derivative
01/23/2002EP1173426A1 Cyclocarbamate derivatives as progesterone receptor modulators
01/23/2002EP1173421A2 Indole derivatives as anti-inflammation agents
01/23/2002EP1173265A1 Sonic impinging jet crystallization apparatus and process
01/23/2002EP1173176A1 Utilization of polycyclic 2-amino-thiazole systems in the production of medicaments for prophylaxis or treatment of obesity
01/23/2002EP1173170A1 Pyrrolidine modulators of chemokine receptor activity